Summary
The regional distribution and the pharmacology of the binding sites labelled with the novel 5-hydroxytryptamine (serotonin) 5-HT1B/1D selective radioligand serotonin-O-carboxy-methyl-glycyl-[125I]tyrosinamide (abbreviated [125I]GTI for the sake of simplicity) was determined using quantitative autoradiography in rat brain. The distribution of [125I]GTI binding sites was largely comparable to that of [125I] iodocyanopindolol ([125I] ICYP) which labels 5-HT1B binding sites (in the presence of 8-OH-DPAT (8-hydroxy-[2N-dipropylamino]tetralin) and isoprenaline, to prevent binding to 5-HT1A and β-adrenoceptor binding sites), although a detailed analysis revealed differences.
The pharmacology of the [125I]GTI binding sites was analysed using compounds known to display high affinity for and/or distinguish between 5-HT1B and 5-HT1D sites: 5-carboxamidotryptamine (5-CT), sumatriptan, CP 93129 (5-hydroxy-3(4-1,2,5,6-tetrahydropyridyl)-4-azaindole), (−)pindolol, PAPP (4[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl] benzeneamine), rauwolscine, and 8-OH-DPAT. The displacement of [125I]GTI by 5-CT was monophasic. By contrast, the selective 5-HT1B compound CP 93129 and (−)pindolol produced biphasic curves showing a majority of high affinity sites in the globus pallidus and the substantia nigra, whereas PAPP and sumatriptan (which are somewhat 5-HT1D selective) produced biphasic curves indicating a minority of high affinity sites in these areas. In addition, by blocking the 5-HT1B sites with 100 nM CP 93129, the remaining population of [125I]GTI binding sites could be studied and was found to have high affinity for PAPP, rauwolscine and 8-OH-DPAT. The pharmacological profile of the major binding component was typical of the 5-HT1B type: 5-CT > CP 93129 ⩾ (−)pindolol > sumatriptan >/ PAPP > rauwolscine. The profile of the minor component of [125I] GTI binding is best characterised as that of a 5-HTID site: 5-CT > PAPP ⩾ sumatriptan > rauwolscine > (−)pindolol ⩾ CP 93129.
The localisation of the non 5-HT1B [125I]GTI binding sites was characterised by blocking the 5-HT1B receptors with 100 nM CP 93129. Low densities of the 5-HT1D recognition sites were found to be present in globus pallidus, ventral pallidum, caudate-putamen, subthalamic nucleus, entopeduncular nucleus, substantia nigra (reticular part), nuclei of the (normal and accessory) optic tract, different nuclei of the geniculate body and frontoparietal cortex, although higher densities of 5-HT1B sites were always observed in the same structures. Thus, in agreement with the recent cloning of a rat 5-HT1Dα receptor cDNA, the presence and the distribution of 5-HT1D sites could be documented in rat brain. However, when compared to 5-HT1B sites, 5-HT1D sites represent only a minor component of the [125I]GTI binding in the rat brain structures studied.
Similar content being viewed by others
References
Adham N, Romanienko P, Hartig P, Weinshank RL, Branchek T (1992) The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1Dβ receptor. Mol Pharmacol 41:1–7
Amlaiky N, Ramboz S, Boschert U, Plassat J-L, Hen R (1992) Isolation of a mouse “5-HT1E-like” serotonin receptor expressed predominantly in the hippocampus. J Biol Chem 267:19761–19764
Berendsen HHG, Broekkamp CLE (1991) A peripheral 5-HT1D-like receptor involved in serotonergic induced hindlimb scratching in rats. Eur J Pharmacol 194:201–208
Bouhelal R, Smounya L, Bockaert J (1988) 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra. Eur J Pharmacol 151:189–196
Boulenguez P, Chauveau J, Segu L, Morel A, Delaage M, Lanoir J (1991) Pharmacological characterization of serotonin-O-carboxymethyl-glycyl-tyrosinamide, a new selective indolic ligand for 5-hydroxytryptamine (5-HT)1B and 5-HT1D binding sites. J Pharmacol Exp Ther 259:1360–1365
Boulenguez P, Segu L, Chauveau J, Morel A, Lanoir J, Delaage M (1992) Biochemical and pharmacological characterization of serotonin-O-carboxymethylglycyl[125I]iodotyrosinamide, a new radioiodinated probe for 5-HT1B and 5-HT1D binding sites. J Neurochem 58:951–959
Bruinvels AT, Landwehrmeyer B, Waeber C, Palacios JM, Hoyer D (1991) Homogeneous 5-HT1D recognition sites in the human substantia nigra identified with a new iodinated radioligand. Eur J Pharmacol 202:89–91
Bruinvels AT, Lery H, Nozulak J, Palacios JM, Hoyer D (1992) 5-HT1D binding sites in various species: similar pharmacological profile in calf, guinea-pig, dog, monkey and human brain membranes. Naunyn-Schmiedeberg's Arch Pharmacol 346:243–249
Bruinvels AT, Palacios JM, Hoyer D (1993) 5-Hydroxytryptamine1 recognition sites in rat brain: Heterogeneity of non-5-hydroxytryptamine1A/1C binding sites revealed by quantitative receptor autoradiography. Neuroscience 53:465–473
Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J (1988) A non-classical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol 34:880–887
Engel G, Göthert M, Hoyer D, Schlicker E, Hillenbrand K (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 332:1–7
Galzin AM, Poirier MF, Lista A, Chodkiewicz JP, Blier P, Ramdine R, Loo H, Roux FX, Redondo A, Langer SZ (1992) Characterization of the 5-hydroxytryptamine receptor modulating the release of [3H]5-hydroxytryptamine in slices of the human neocortex. J Neurochem 59:1293–1301
Hamblin MW, Metcalf MA (1991) Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor. Mol Pharmacol 40:143–148
Hamblin MW, Metcalf MA, McGuffin RW, Karpells S (1992a) Molecular cloning and functional characterization of a human 5-HT1B serotonin receptor: a homologue of the rat 5-HT1B receptor with a 5-HT1D-like pharmacological specificity. Biochem Biophys Res Commun 184:752–759
Hamblin MW, McGuffin RW, Metcalf MA, Dorsa DM, Merchant KM (1992b) Distinct 5-HT1B and 5-HT1D receptors in rat: structural and pharmacological comparison of the two cloned receptors. Mol Cell Neurosci 3:578–587
Hartig PR (1989) Molecular Biology of 5-HT receptors. Trends Pharmacol Sci 10:64–69
Hartig PR, Branchek TA, Weinshank, RL (1992) A subfamily of 5-HTID receptor genes. Trends Pharmacol Sci 13:152–159
Herrick-Davis K, Titeler M (1988) Detection and characterization of the serotonin 5-HT1D receptor in rat and human brain. J Neurochem 50:1624–1631
Heuring RJ, Peroutka SJ (1987) Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J Neurosci 7:894–903
Hong JS, Yang HYT, Racagni G, Costa E (1977) Projections of substance P containing neurons from neostriatum to substantia nigra. Brain Res 122:541–544
Hoyer D (1991) The 5-HT receptor family: ligands, distribution and receptor-effector coupling. In: Rodgers RJ, Cooper SJ (eds) 5-HT1A agonists, 5-HT3 antagonists and benzodiazepines: their comparative behavioural pharmacology. Wiley, Chichester, pp 31–57
Hoyer D, Engel G, Kalkman HO (1985) Characterization of the 5-HT1B recognition site in rat brain: binding studies with [125I]iodocyanopindolol. Eur J Pharmacol 118:1–12
Hoyer D, Lery H, Nozulak J, Palacios JM, Bruinvels AT (1992) ‘5-HT1R’ or 5-HT1D binding? Evidence for 5-HT1D binding in rabbit brain. Naunyn-Schmiedeberg's Arch Pharmacol 346:249–255
Hoyer D, Middlemiss DN (1989) The pharmacology of the terminal 5-HT autoreceptors in mammalian brain: evidence for species differences. Trends Pharmacol Sci 10:130–132
Hoyer D, Schoeffter P (1988) 5-HT1D receptors inhibit forskolin-stimulated adenylate cyclase activity in calf substantia nigra. Eur J Pharmacol 147:145–147
Jin H, Oksenberg D, Askenazi A, Peroutka SJ, Duncan AMV, Rozmahel R, Yang Y, Mengod G, Palacios JM, O'Dowd BF (1992) Characterization of the human 5-hydroxytryptamine1B receptor. J Biol Chem 267:5735–5738
Levy FO, Gudermann T, Birnbaumer M, Kaumann AJ, Birnbaumer L (1992) Molecular cloning of a human gene (S31) encoding a novel serotonin receptor mediating inhibition of adenylyl cyclase. FEBS Lett 296:201–206
Limberger N, Deicher R, Starke K (1991) Species differences in presynaptic serotonin autoreceptors: mainly 5-HT1B but possibly in addition 5-HT1D in the rat, 5-HT1D in the rabbit and guinea-pig brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 343: 353–364
Macor JE, Burkhart CA, Heym JH, Ives JL, Lebel LA, Newman ME, Nielsen JA, Ryan K, Schulz DW, Torgersen LK, Koe BK (1990) 3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo[3, 2-b]pyrid-5-one a potent and selective serotonin 5-HT1B agonist and rotationally restricted phenolic analogue of 5 methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole. J Med Chem 33:2087–2093
Maroteaux L, Saudou F, Amlaiky N, Boschert U, Plassat JL, Hen R (1992) The mouse 5HT1B serotonin receptor: cloning, functional expression and localisation in motor control centers. Proc Natl Acad Sci USA 89:3020–3024
Maura G, Raiteri M (1986) Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetycholine release. Eur J Pharmacol 129:333–337
Maura G, Roccatagliata E, Raiteri M (1986) Serotonin autoreceptor in rat hippocampus: Pharmacological characterization as a subtype of the 5-HT1 receptor. Naunyn-Schmiedeberg's Arch Pharmacol 334:323–326
McAllister G, Charlesworth A, Snodin C, Beer MS, Noble AJ, Middlemiss DN, Iversen LL, Whiting P (1992) Molecular cloning of a serotonin receptor from human brain (5-HT1E): a fifth 5-HT1-like subtype. Proc Natl Acad Sci USA 89:5517–5521
Middlemiss DN, Bremer ME, Smith SM (1988) A pharmacological analysis of the 5-HT receptors mediating inhibition of 5-HT release in the guinea-pig frontal cortex. Eur J Pharmacol 157:101–107
Palacios JM, Waeber C, Bruinvels AT, Hoyer D (1992) Direct visualization of serotonin1D receptors in the human brain using a new radioiodinated radioligand. Mol Brain Res 13:175–179
Pazos A, Palacios JM (1985) Quantitative auto- radiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346:205–230
Pazos A, Engel G, Palacios JM (1985) Beta-adrenoreceptor blocking agents recognize a subpopulation of serotonin receptors in brain. Brain Res 343:403–408
Pedigo NW, Yamamura HI, Nelson DL (1981) Discrimination of multiple [3H]5-hydroxytryptamine-binding sites by the neuroleptic spiperone in rat brain. J Neurochem 36:220–226
Peroutka SJ (1988) 5-Hydroxytryptamine receptor subtypes: Molecular, biochemical and physiological characterization. Trends Neurosci 11:496–499
Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol 16:687–699
Ribak CE, Vaughn JE, Roberts E (1980) GABAergic nerve terminals decrease in substantia nigra following hemitransections of striatonigral and pallidonigral pathways. Brain Res 192:413–420
Schipper J, Tulp MTM (1988) Serotonin autoreceptors in guinea pig cortex slices resemble the 5-HT1D binding site. Soc Neurosci Abstr 14:552
Schlicker E, Fink K, Göthert M, Hoyer D, Molderings G, Roschke I, Schoeffter P (1989) The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype. Naunyn-Schmiedeberg's Arch Pharmacol 340:45–51
Schoeffter P, Hoyer D (1989) 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity pharmacological comparison with special reference to the effects of yohimbine rauwolscine and some beta-adrenoceptor antagonists. Naunyn-Schmiedeberg's Arch Pharmacol 340:285–292
Sijbesma H, Schipper J, Cornelissen JCHM, De Kloet ER (1991) Species differences in the distribution of central 5-HT1 binding sites a comparative autoradiographic study between rat and guinea-pig. Brain Res 555:295–304
Vergé D, Daval G, Marcinkiewicz M, Patey A, El Mestikawy S, Gozlan H, Hamon M (1986) Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci 6:3474–3482
Voigt MM, Laurie DJ, Seeburg PH, Bach A (1991) Molecular cloning and characterization of a rat brain cDNA encoding a 5-hydroxytryptamine 1B receptor. EMBO J 10:4017–4023
Waeber C, Palacios JM (1992) Autoradiographic evidence that non 5-HT1A/5-HT1C [3H]5-HT binding sites are of the 5-HT1B subtype in the hamster and opossum brain, of the 5-HT1D subtype in the rabbit brain. Synapse 12:261–270
Waeber C, Schoeffter P, Palacios JM, Hoyer D (1988) Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. Naunyn Schmiedeberg's Arch Pharmacol 337:595–601
Waeber C, Dietl MM, Hoyer D, Palacios JM (1989a) 5-HT1 receptors in the vertebrate brain. Regional distribution examined by autoradiography. Naunyn-Schmiedeberg's Arch Pharmacol 340:486–494
Waeber C, Schoeffter P, Palacios JM, Hoyer D (1989b) 5- HT(1D) receptors in guinea-pig and pigeon brain. Radioligand binding and biochemical studies. Naunyn-Schmiedeberg's Arch Pharmacol 340:479–485
Weinshank RL, Zgombick JM, Macchi M, Branchek TA, Hartig PR (1992) Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1Dα and 5-HTID1Dβ. Proc Natl Acad Sci USA 89:3630–3634
Zarbin MA, Palacios JM, Wamsley JK, Kuhar MJ (1983) Axonal transport of beta-adrenergic receptors: antero- and retrogradely transported receptors differ in agonist affinity and nucleotide sensitivity. Mol Pharmacol 24:341–348
Author information
Authors and Affiliations
Additional information
Correspondence to: D. Hoyer at the above address
Rights and permissions
About this article
Cite this article
Bruinvels, A.T., Palacios, J.M. & Hoyer, D. Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 347, 569–582 (1993). https://doi.org/10.1007/BF00166939
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00166939